The global perfusion bioreactors market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biopharmaceuticals and biotechnology products in emerging economies such as China and India. The increasing number of clinical trials in these countries also drives the growth of this market.
The small scale perfusion bioreactors segment accounted for a share of over 50% in 2017, owing to their low cost and easy installation. Large scale perfusion bioreactors are used by large pharmaceutical companies for manufacturing high volume products such as vaccines, monoclonal antibodies, recombinant proteins, etc, which account for a share of over 50%. Biopharmaceutical companies accounted for a share of over 60% in 2017 owing to their increased focus on research and development activities that require large-scale production facilities with advanced technologies. Contract manufacturing organizations are expected to witness significant growth during the forecast period owing to their ability to provide services at lower costs than other players in this industry due to economies of scale achieved through outsourcing production processes from other manufacturers or suppliers.
- The increasing demand for biopharmaceuticals and the need to produce them in a cost-effective manner is driving the growth of the perfusion bioreactors market.
- The increasing number of clinical trials and research activities in the field of regenerative medicine is also driving the growth of this market.
- The growing awareness about stem cell therapy, which has been shown to be effective in treating various diseases, is also expected to drive this market's growth over the forecast period.
- Increasing government funding for research and development activities related to regenerative medicine is expected to fuel this market's growth over the forecast period.
- Increasing focus on developing new technologies that can be used for manufacturing biopharmaceuticals at a lower cost will also fuel this market's growth over the forecast period.
Industry Growth Insights published a new data on “Perfusion Bioreactors Market”. The research report is titled “Perfusion Bioreactors Market research by Types (Small Scale Perfusion Bioreactors, Large Scale Perfusion Bioreactors), By Applications (Biopharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations), By Players/Companies Sigma Aldrich, FiberCell Systems, Zellwerk, Cell Culture, ATMI, PBS Biotech, GE Healthcare Life Sciences, Applikon Biotechnology, WAVE Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Perfusion Bioreactors Market Research Report
By Type
Small Scale Perfusion Bioreactors, Large Scale Perfusion Bioreactors
By Application
Biopharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations
By Companies
Sigma Aldrich, FiberCell Systems, Zellwerk, Cell Culture, ATMI, PBS Biotech, GE Healthcare Life Sciences, Applikon Biotechnology, WAVE Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Perfusion Bioreactors Market Report Segments:
The global Perfusion Bioreactors market is segmented on the basis of:
Types
Small Scale Perfusion Bioreactors, Large Scale Perfusion Bioreactors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sigma Aldrich
- FiberCell Systems
- Zellwerk
- Cell Culture
- ATMI
- PBS Biotech
- GE Healthcare Life Sciences
- Applikon Biotechnology
- WAVE Life Sciences
Highlights of The Perfusion Bioreactors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Scale Perfusion Bioreactors
- Large Scale Perfusion Bioreactors
- By Application:
- Biopharmaceutical Companies
- Biotechnology Companies
- Contract Manufacturing Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Perfusion Bioreactors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Perfusion bioreactors are a type of bioreactor that use a perfusion process to circulate blood and other fluids throughout the reactor. This helps to increase the rate at which nutrients and chemicals can be delivered to the cells, leading to increased production.
Some of the key players operating in the perfusion bioreactors market are Sigma Aldrich, FiberCell Systems, Zellwerk, Cell Culture, ATMI, PBS Biotech, GE Healthcare Life Sciences, Applikon Biotechnology, WAVE Life Sciences.
The perfusion bioreactors market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Perfusion Bioreactors Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Perfusion Bioreactors Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Perfusion Bioreactors Market - Supply Chain
4.5. Global Perfusion Bioreactors Market Forecast
4.5.1. Perfusion Bioreactors Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Perfusion Bioreactors Market Size (000 Units) and Y-o-Y Growth
4.5.3. Perfusion Bioreactors Market Absolute $ Opportunity
5. Global Perfusion Bioreactors Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Perfusion Bioreactors Market Size and Volume Forecast by Type
5.3.1. Small Scale Perfusion Bioreactors
5.3.2. Large Scale Perfusion Bioreactors
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Perfusion Bioreactors Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Perfusion Bioreactors Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. Biotechnology Companies
6.3.3. Contract Manufacturing Organizations
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Perfusion Bioreactors Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Perfusion Bioreactors Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Perfusion Bioreactors Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Perfusion Bioreactors Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Perfusion Bioreactors Demand Share Forecast, 2019-2029
9. North America Perfusion Bioreactors Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Perfusion Bioreactors Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Perfusion Bioreactors Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. Biotechnology Companies
9.4.3. Contract Manufacturing Organizations
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Perfusion Bioreactors Market Size and Volume Forecast by Type
9.7.1. Small Scale Perfusion Bioreactors
9.7.2. Large Scale Perfusion Bioreactors
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Perfusion Bioreactors Demand Share Forecast, 2019-2029
10. Latin America Perfusion Bioreactors Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Perfusion Bioreactors Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Perfusion Bioreactors Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. Biotechnology Companies
10.4.3. Contract Manufacturing Organizations
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Perfusion Bioreactors Market Size and Volume Forecast by Type
10.7.1. Small Scale Perfusion Bioreactors
10.7.2. Large Scale Perfusion Bioreactors
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Perfusion Bioreactors Demand Share Forecast, 2019-2029
11. Europe Perfusion Bioreactors Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Perfusion Bioreactors Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Perfusion Bioreactors Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. Biotechnology Companies
11.4.3. Contract Manufacturing Organizations
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Perfusion Bioreactors Market Size and Volume Forecast by Type
11.7.1. Small Scale Perfusion Bioreactors
11.7.2. Large Scale Perfusion Bioreactors
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Perfusion Bioreactors Demand Share, 2019-2029
12. Asia Pacific Perfusion Bioreactors Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Perfusion Bioreactors Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Perfusion Bioreactors Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. Biotechnology Companies
12.4.3. Contract Manufacturing Organizations
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Perfusion Bioreactors Market Size and Volume Forecast by Type
12.7.1. Small Scale Perfusion Bioreactors
12.7.2. Large Scale Perfusion Bioreactors
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Perfusion Bioreactors Demand Share, 2019-2029
13. Middle East & Africa Perfusion Bioreactors Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Perfusion Bioreactors Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Perfusion Bioreactors Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. Biotechnology Companies
13.4.3. Contract Manufacturing Organizations
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Perfusion Bioreactors Market Size and Volume Forecast by Type
13.7.1. Small Scale Perfusion Bioreactors
13.7.2. Large Scale Perfusion Bioreactors
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Perfusion Bioreactors Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Perfusion Bioreactors Market: Market Share Analysis
14.2. Perfusion Bioreactors Distributors and Customers
14.3. Perfusion Bioreactors Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sigma Aldrich
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. FiberCell Systems
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zellwerk
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cell Culture
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ATMI
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PBS Biotech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GE Healthcare Life Sciences
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Applikon Biotechnology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. WAVE Life Sciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
